FDA Approval Archives - Metastatic Breast Cancer Trial Talk

Home > FDA Approval

CURRENT ARTICLE - August 2022

FDA Approves Enhertu® for HER2-Low MBC

Read about the recent approval of Enhertu® for HER2-low MBC.

PAST ARTICLES

2022

FDA Expands Approval for Enhertu®

2021

2020

2019

New FDA Approval: A PI3K Inhibitor

SEARCH OUR SITE

for past articles or specific information.